KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • Thermo Fisher Scientific's Other Non-Current Liabilities fell 149.67% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 149.67%. This contributed to the annual value of $4.0 billion for FY2024, which is 1406.72% down from last year.
  • Thermo Fisher Scientific's Other Non-Current Liabilities amounted to $4.3 billion in Q3 2025, which was down 149.67% from $4.3 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Other Non-Current Liabilities' 5-year high stood at $4.7 billion during Q2 2022, with a 5-year trough of $3.4 billion in Q2 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $4.3 billion (2025), whereas its average is $4.2 billion.
  • In the last 5 years, Thermo Fisher Scientific's Other Non-Current Liabilities surged by 3914.08% in 2022 and then plummeted by 1406.72% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Other Non-Current Liabilities (Quarter) stood at $4.5 billion in 2021, then fell by 6.65% to $4.2 billion in 2022, then increased by 9.53% to $4.6 billion in 2023, then decreased by 14.07% to $4.0 billion in 2024, then increased by 7.24% to $4.3 billion in 2025.
  • Its Other Non-Current Liabilities was $4.3 billion in Q3 2025, compared to $4.3 billion in Q2 2025 and $4.0 billion in Q1 2025.